Share on StockTwits

MedAssets (NASDAQ:MDAS) Director Terrence J. Mulligan sold 1,000 shares of MedAssets stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $23.30, for a total transaction of $23,300.00. Following the completion of the sale, the director now directly owns 927 shares of the company’s stock, valued at approximately $21,599. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

MedAssets (NASDAQ:MDAS) traded down 0.73% during mid-day trading on Monday, hitting $23.05. 377,820 shares of the company’s stock traded hands. MedAssets has a 1-year low of $17.03 and a 1-year high of $26.58. The stock has a 50-day moving average of $23.19 and a 200-day moving average of $22.52. The company has a market cap of $1.406 billion and a P/E ratio of 52.77.

MedAssets (NASDAQ:MDAS) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $0.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by $0.01. Analysts expect that MedAssets will post $1.37 EPS for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Citigroup Inc. downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 29th. They now have a $26.00 price target on the stock, down previously from $28.00. Separately, analysts at Bank of America downgraded shares of MedAssets from a “buy” rating to a “neutral” rating in a research note on Thursday, May 22nd. They now have a $24.00 price target on the stock, down previously from $25.00. Finally, analysts at Stephens initiated coverage on shares of MedAssets in a research note on Tuesday, May 20th. They set an “equal weight” rating and a $20.00 price target on the stock. Twelve equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $25.28.

MedAssets, Inc (NASDAQ:MDAS) provides technology-enabled products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.